The material on this site is for financial institutions, professional investors and their professional advisers. It is for information only. Please read our Terms & Conditions, Privacy Policy and Cookies before using this site. Please see our Subscription Terms and Conditions.


All material subject to strictly enforced copyright laws. © 2021 Euromoney, a part of the Euromoney Institutional Investor PLC.

Munich Re sells the ultimate risk

Insurance and capital markets: convergence or collision course?


insurance-h5n1.gif

In February 2008, Munich Re unveiled an unusual $1.5 billion programme for transferring extreme mortality risk to the capital markets. Through an issuing vehicle, Nathan, it launched an initial $100 million of principal-at-risk variable rate notes paying Libor plus 135 basis points to protect the company against large losses deriving from an exceptional rise in mortality rates in the US, Canada, England and Wales, and Germany.

What might trigger such a distressing event? A nuclear war would do it. More likely, it would be an outbreak of bird flu leading to a human pandemic. The World Health Organization has been notified of 348 cases of human infection with H5N1, resulting in 216 deaths between January 2004 and January 2008. Most cases of human infection have been linked directly to contact with infected poultry or contaminated surfaces, although the first human-to-human infection was reported in Indonesia in May 2006.

Governments and large companies have been considering how to respond to any pandemic break-out.

"This is a five-year deal," says Rupert Flatscher, head of the risk trading unit at Munich Re.


You have reached premium content. Please log in to continue reading.

Read beyond the headlines with Euromoney

For over 50 years, our readers have looked to Euromoney to stay informed about the issues that matter in the international banking and financial markets. Find out more about our different levels of access below.

SUBSCRIBE ONLINE TODAY

Unlimited access to Euromoney.com and Asiamoney.com

Expert comment, long reads and in-depth analysis interviews with senior finance professionals

Access the results of our market-leading annual surveys across core financial services

Access the results of our annual awards, including the world-renowned Awards for Excellence

Your print copy of Euromoney magazine delivered monthly

£73.75 per month

Billed Annually

FREE 7 DAY TRIAL

Unlimited access to Euromoney.com and Asiamoney.com, including our top stories, long reads, expert analysis, and the results of our annual surveys and awards

Sign up to any of our newsletters, curated by our editors

LOGIN NOW

Already a user?

We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree